Daniel Havas

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD”.

Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD

Neurobiology of Disease(2023)10.1016/j.nbd.2023.106050

N/A

0DataRank · unranked

35 citations

Elodie Chevalier, Mickaël Audrain, Christopher Dumayne, Tamar Ziehm, Roger Moser +21 more

Preclinical characterization and IND‐enabling safety studies for PNT001, an antibody that recognizes cis‐pT231 tau

Alzheimer s & Dementia(2023)10.1002/alz.13028

N/A

0DataRank · unranked

14 citations

Matteo Manca, Kim F. McClure, Pyry Koivula, John Q. Trojanowski, Daniel Havas +6 more